Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.
Condition(s) studied
Investigational drug(s) / intervention(s)
mindfulness intervention: The mindfulness program is conducted in a group session of up to 10 people. Each session lasts 2 hours. A total of 12 sessions will be conducted by a practitioner who is specifically trained in this type of programme.
psycho educative programme: The psycho-educational control intervention will follow the same format and structure as the mindfulness meditation intervention in terms of group format, session duration and frequency. This is a therapeutic education programme developed for several years in the neurology department of the university hospital of Lyon and Grenoble. The program follows the repository recommended by the french league against epilepsy.
Study summary
This study evaluates a mindfulness intervention in patients with drug resistant epilepsy.
Half of participants will follow a mindfulness programme, while the other half will follow a self management programme.
Eligibility
Primary outcome measure(s)
- Evolution of Quality Of Life In Epilepsy-Problems questionnaire (QOLIE31-P) score. — 9 months
The QOLIE31-P questionnaire has been developed specifically to measure the quality of life of patients with epilepsy. The score ranges from 0 to 100 points. Higher scores reflect better quality of life; lower ones, worse quality of life. The score of QOLIE31-P will be assess prior to intervention and then at month 3, month 6 and month 9 after the beginning of the intervention. Ref : Cramer JA. Van Hammee G. N132 Study Group. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy \& Behavior 2003; 4:118-123.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Epileptology Department of The Grenoble University Hospital | Grenoble | France | Recruiting |
| Epileptology Department of the Lyon University Hospital | Lyon | France | Not Yet Recruiting |
| La Teppe medical centre | Tain-l'Hermitage | France | Not Yet Recruiting |
More University Hospital, Grenoble trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04126369 on ClinicalTrials.gov ↗ ← All trials in France